NSOC 2014
5th Serbian-French Novi Sad Oncology Congress
21-22 March, 2014
Topic: Advanced Breast Cancer
ORGANIZING COMMITTEE
Prof. Dr Darjana Jovanovic, Oncology Institute of Vojvodina, Serbia
Prof. Dr Jean-Pierre Lotz, Hôpital Tenon, Assistance Publique – Hôpitaux de Paris, France
Prof. Dr Milos Lucic, Oncology Institute of Vojvodina, Serbia
Prof. Dr Dusan Jovanovic, Oncology Institute of Vojvodina, Serbia
Prof. Dr Yazid Belkacemi, Université Paris-Est Créteil (UPEC), Paris XII, France
Prof. Dr Slavica Knezevic-Usaj, Oncology Institute of Vojvodina, Serbia
Prof. Dr Marko Erak, Oncology Institute of Vojvodina, Serbia
Prof. Dr Milan Breberina, Oncology Institute of Vojvodina, Serbia
Prof. Dr Andrija Golubovic, Oncology Institute of Vojvodina, Serbia
Doc. Dr Ferenc Vicko, Oncology Institute of Vojvodina, Serbia
Doc. Dr Aljosa Mandic, Oncology Institute of Vojvodina, Serbia
Asist. Dr Lazar Popovic, Oncology Institute of Vojvodina, Serbia
CONGRESS SECRETARIAT
Dr Tatjana Roganovic, Oncology Institute of Vojvodina, Serbia
Dr Dušanka Tešanovic, Oncology Institute of Vojvodina, Serbia
Dr Ivana Kolarov-Bjelobrk, Oncology Institute of Vojvodina, Serbia
Dr Danijela Petkovic, Oncology Institute of Vojvodina, Serbia
Dr Jelena Vukojevic, Oncology Institute of Vojvodina, Serbia
Dr Vladimir Vidovic, Oncology Institute of Vojvodina, Serbia
Dr Bojana Rimski, Oncology Institute of Vojvodina, Serbia
Asist. Dr Branislav Djuran, Oncology Institute of Vojvodina, Serbia
Asist. Dr Gorana Matovina-Brko, Oncology Institute of Vojvodina, Serbia
Dr Nemanja Petrović, Oncology Institute of Vojvodina, Serbia
VENUE: Hotel „Novi Sad“, Novi Sad, Serbia
OFFICIAL LANGUAGE : English
REGISTRATION FEE: 3000,00 RSD or 30 EUR
CME ACCREDITATED FROM „ZDRAVSTVENI SAVET SRBIJE“
APLICATIONS FOR THE CONGRESS AND HOTEL ACCOMMODATION:
PANACOMP, Novi Sad
Phone Numbers: +381 21 466 075
+381 21 466 076
CONTACT PERSON: Jadranka Petrović (Technical Organiser)
Cell phone: + 381 63 549 317 E-mail: [email protected]
http://www.panacomp.net
http://www.onk.ns.ac.rs/novosti.htm
FRIDAY March 21, 2014
08.00-17.00 Registration
08.30 Opening ceremony
09.00-09.50 Morning session: Locally advanced breast cancer
09.00-09.20 Prof. Dr Yann Delpech, Paris, France
09.20-09.50 Prof. Dr Maurice Mimoun, Paris, France
09.50-11.30 Morning Session: Role of surgery in metastatic breast cancer
09.50-10.10 Breast surgery in metastatic breast cancer patient Doc. Dr Ferenc Vicko, S.
Kamenica, Serbia
10.10-10.40 Surgery for breast cancer visceral metastases Prof. Francois Guillemin, Nancy
France
10.40-11.10 Surgery for breast cancer bone metastases Prof. Dr Thierry Judet, Paris, France
11.10-11-30 Discussion
11.30-12.30 ROCHE Satellite Symposium
12.30-14.00 Lunch Break
14.00-18.00 Afternoon session: Medical Oncology
14.00-14.20 When to re-biopsy a patient? Which impact? Dr Martine Antoine, Paris, France
14.20-14.40 Therapy for metastatic triple negative breast cancer Dr Jasna Pesic, S.
Kamenica, Serbia
14.40-15.00 Treatment fo Her2-positive metastatic breast cancer patient Prof. Dr Jasna
Trifunovic, S. Kamenica, Serbia
15.00-15.20 How to treat asymptomatic ER-positive, Her2-negative breast cancer patient Dr
Suzana Vasovic, Belgrade, Serbia
15.30-16.30 GLAXO SMITH KLINE Meeting with Coffee Break
16.30-16.50 New targeted therapy for metastatic breast cancer Dr Ljiljana Stamatovic,
Belgrade, Serbia
16.50-17.10 Treatment for breast cancer CNS metastases Dr Dusica Stojanovic, Nis, Serbia
17.10-17.30 Role of radiation therapy in oligometastastic breast carcinomas Dr Francoise
Pene, Paris, France
17.30-17.50 Can we cure a patient with metastatic breast cancer? DR Dragutin Donat, S.
Kamenica, Serbia
17.50
Conclusion Prof. Dr Jean-Pierre Lotz, Paris, France
SATURDAY March 22, 2014
09.00-11.00 AROME SESSION
09.00-09.45 A systems biology framework for understanding response and resistance to
cancer therapies Prof. Dr Yosef Yarden, Rehovot, Israel
09.45-10.15 Emerging concepts of breast cancer radiotherapy: tailoring strategy to tumor
biology Dr Pelagia Tsoutsou, Lausanne, Switzerland
10.15-10.45 Is there a role for loco-regional treatment of the primary tumor in metastatic
breast cancer? Prof. DR Abraham Kuten, Haifa, Israel
10.45-11.00 Discussion
11.00-12.15 Young doctors/students session
11.00-11.15 Pain magement
11.15-11.30 Anti-Emesis Support
11.30-11.45 Supportive care during radiotherapy
11.45-12.00 Haematopoietic support (G-CSF)
12.00-12.15 Haematopoietic support (EPO)
Discussion and NSOC young students award
CONCLUSION
Dr Ana Cvetanovic Nis, Serbia
Aleksandra Vejnovic Novi Sad, Serbia
Dr Milana Mitric S. Kamenica, Serbia
Vadim Afanassiev Paris, France
Sandra Assoun Paris, France
Download

ORGANIZING COMMITTEE